GoodBelly, a recognized pioneer in the burgeoning gut health sector, has successfully secured $10.0 million in its latest funding round. This substantial investment marks a significant milestone for the company, which remains dedicated to improving people's lives with intestinal balance, digestive wellbeing, and immunity support when consumed daily. The capital infusion is poised to support GoodBelly's ongoing mission to provide efficacious and accessible solutions in the rapidly expanding health and wellness market.
Founded in 2006, GoodBelly has established itself by bringing probiotics to the mainstream. The company's product offerings, which include everyday foods, beverages, and supplements, rely on well-studied probiotic strains such as DE111® and Lactiplantibacillus Plantarum 299v (LP299V®). Headquartered in Boulder, Colorado, GoodBelly products are widely available at stores nationwide, spanning natural, specialty, conventional, mass, and convenience retailers.
The newly raised $10.0 million will be strategically deployed to fuel GoodBelly's ambitious growth initiatives. The company plans to use the funds to accelerate its research and development efforts, enabling the creation of new and innovative product offerings. Furthermore, the capital will support the expansion of its existing product portfolio and enhance its market reach across various retail channels, aiming to make its beneficial products available to an even wider consumer base. This investment underscores a clear commitment to scaling operations and meeting the increasing consumer demand for science-backed gut health solutions.
This funding round positions GoodBelly to further solidify its leadership in the functional food and supplement space. The company aims to continue its trajectory of innovation and expansion, reinforcing its commitment to improving digestive health and overall wellbeing for consumers nationwide through accessible and effective probiotic products.
.png&w=3840&q=75)
